This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Early Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
May 9-12, 2022 | In-Person + DigitalHynes Convention Center, Boston

Daniel Harris, PhD
Director of Drug Manufacturing and Supply Chain at Lumicell


Daniel Harris leads the development and manufacturing of Lumicell’s imaging agent. His background is in the development of fluorescent materials for in vivo imaging, lighting and display technologies. He holds a PhD in materials science from MIT.

Agenda Sessions

  • Development of Pegulicianine, A Novel Activatable Fluorescent Imaging Agent for Intraoperative Cancer Detection